Cargando…

Effect of Rivastigmine on Mobility of Patients with Higher-Level Gait Disorder: A Pilot Exploratory Study

BACKGROUND: Higher-level gait disorder (HLGD) in older adults is characterized by postural instability, stepping dysrhythmicity, recurrent falls and progressive immobility. Cognitive impairments are frequently associated with HLGD. OBJECTIVES: The aim of this study was to compare gait and cognitive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gurevich, Tanya, Balash, Yacov, Merims, Doron, Peretz, Chava, Herman, Talia, Hausdorff, Jeffrey M., Giladi, Nir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2014
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070456/ https://www.ncbi.nlm.nih.gov/pubmed/24723147 http://dx.doi.org/10.1007/s40268-014-0038-8

Ejemplares similares

Effect of gait speed on gait rhythmicity in Parkinson's disease: variability of stride time and swing time respond differently
por: Frenkel-Toledo, Silvi, et al.
Publicado: (2005)

Disorders of the Oral Cavity in Parkinson's Disease and Parkinsonian Syndromes
por: Zlotnik, Yair, et al.
Publicado: (2015)

Shedding light on walking in the dark: the effects of reduced lighting on the gait of older adults with a higher-level gait disorder and controls
por: Kesler, Anat, et al.
Publicado: (2005)

White Matter Hyperintensities in Parkinson’s Disease: Do They Explain the Disparity between the Postural Instability Gait Difficulty and Tremor Dominant Subtypes?
por: Herman, Talia, et al.
Publicado: (2013)

SPARC: a new approach to quantifying gait smoothness in patients with Parkinson’s disease
por: Beck, Yoav, et al.
Publicado: (2018)

A meta-analysis identifies factors predicting the future development of freezing of gait in Parkinson’s disease
por: Herman, Talia, et al.
Publicado: (2023)

Comparison of Selegiline and Rasagiline Therapies in Parkinson Disease: A Real-life Study
por: Peretz, Chava, et al.
Publicado: (2016)

Statin adherence and the risk of Parkinson's disease: A population-based cohort study
por: Rozani, Violetta, et al.
Publicado: (2017)

Is Freezing of Gait in Parkinson's Disease a Result of Multiple Gait Impairments? Implications for Treatment
por: Plotnik, Meir, et al.
Publicado: (2012)

Multidisciplinary Intensive Rehabilitation Program for People with Parkinson’s Disease: Gaps between the Clinic and Real-World Mobility
por: Cohen, Moriya, et al.
Publicado: (2023)

Using Wearable Sensors and Machine Learning to Automatically Detect Freezing of Gait during a FOG-Provoking Test
por: Reches, Tal, et al.
Publicado: (2020)

Objective Assessment of Fall Risk in Parkinson's Disease Using a Body-Fixed Sensor Worn for 3 Days
por: Weiss, Aner, et al.
Publicado: (2014)

Association between Community Ambulation Walking Patterns and Cognitive Function in Patients with Parkinson's Disease: Further Insights into Motor-Cognitive Links
por: Weiss, Aner, et al.
Publicado: (2015)

Subthalamic Neurons Encode Both Single- and Multi-Limb Movements in Parkinson’s Disease Patients
por: Tankus, Ariel, et al.
Publicado: (2017)

Effects of Aging on Arm Swing during Gait: The Role of Gait Speed and Dual Tasking
por: Mirelman, Anat, et al.
Publicado: (2015)

Daily-Living Freezing of Gait as Quantified Using Wearables in People With Parkinson Disease: Comparison With Self-Report and Provocation Tests
por: Denk, Diana, et al.
Publicado: (2022)

Subcortical Volumes Differ in Parkinson’s Disease Motor Subtypes: New Insights into the Pathophysiology of Disparate Symptoms
por: Rosenberg-Katz, Keren, et al.
Publicado: (2016)

Sensor-Based and Patient-Based Assessment of Daily-Living Physical Activity in People with Parkinson’s Disease: Do Motor Subtypes Play a Role?
por: Galperin, Irina, et al.
Publicado: (2020)

Rivastigmine improves dual-task gait velocity in patients with Alzheimer’s disease
por: Shimura, Hideki, et al.
Publicado: (2021)

Executive Function and Falls in Older Adults: New Findings from a Five-Year Prospective Study Link Fall Risk to Cognition
por: Mirelman, Anat, et al.
Publicado: (2012)

Automated detection of missteps during community ambulation in patients with Parkinson’s disease: a new approach for quantifying fall risk in the community setting
por: Iluz, Tal, et al.
Publicado: (2014)

Abnormal gait and motor cortical processing in drug‐resistant juvenile myoclonic epilepsy
por: Maidan, Inbal, et al.
Publicado: (2023)

Combining tDCS With a Motor-Cognitive Task to Reduce the Negative Impact of Dual-Tasking on the Gait of Older Adults
por: Hausdorff, Jeffrey, et al.
Publicado: (2020)

Esophagectasis Related to Rivastigmine
por: Sasaki, Osamu, et al.
Publicado: (2019)

The ReSPonD trial - rivastigmine to stabilise gait in Parkinson’s disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson’s disease who have fallen
por: Henderson, Emily J, et al.
Publicado: (2013)

Higher-Level Cognitive Function and Obstacle Attributes: An fNIRS Study in Older Adults With Parkinson’s Disease
por: Hausdorff, Jeffrey, et al.
Publicado: (2020)

Subthalamic nucleus physiology is correlated with deep brain stimulation motor and non-motor outcomes
por: Levy, Mikael, et al.
Publicado: (2023)

Decreased expression of B cell related genes in leukocytes of women with Parkinson's disease
por: Kedmi, Merav, et al.
Publicado: (2011)

Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study
por: Muñoz-Moreno, Jose A., et al.
Publicado: (2017)

Medical Cannabis for Gilles de la Tourette Syndrome: An Open-Label Prospective Study
por: Anis, Saar, et al.
Publicado: (2022)

Rivastigmine in the treatment of Alzheimer’s disease: an update
por: Onor, Maria Luisa, et al.
Publicado: (2007)

Rivastigmine in the treatment of patients with Alzheimer’s disease
por: Müller, Thomas
Publicado: (2007)

Acquired Localized Hypertrichosis Induced by Rivastigmine
por: Imbernón-Moya, Adrian, et al.
Publicado: (2016)

CCR5‐Δ32 polymorphism—a possible protective factor from gait impairment amongst post‐stroke patients
por: Molad, Jeremy, et al.
Publicado: (2022)

Automated detection of near falls: algorithm development and preliminary results
por: Weiss, Aner, et al.
Publicado: (2010)

A pilot study of rivastigmine in the treatment of delirium after stroke: A safe alternative
por: Oldenbeuving, Annemarie W, et al.
Publicado: (2008)

Higher heritabilities for gait components than for overall gait scores may improve mobility in ducks
por: Duggan, Brendan M., et al.
Publicado: (2017)

An Atypical Cutaneous Reaction to Rivastigmine Transdermal Patch
por: Grieco, T., et al.
Publicado: (2011)

Rivastigmine for the treatment of dementia associated with Parkinson’s disease
por: Reingold, Jennifer L, et al.
Publicado: (2007)

Rivastigmine in Chinese patients with subcortical vascular dementia
por: Mok, Vincent, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_46ec0h91aau332ussvgtqf84q5